SB269970 HCl

More efficient, faster and cheaper. Ace Therapeutics are trustworthy.

sale

SB269970 HCl

Specification
Cat. No.
SMD1772
Related Diseases
Schizophrenia
Product Name
SB269970 HCl
Size
Customizable
Price
Inquiry
Description
SB269970 is a potent 5-HT7A antagonist (pKi = 8.9) that demonstrates >50-fold binding selectivity over 5-HT5A and >250-fold selectivity over 5-HT1, 5-HT2, 5-HT4, 5-HT6, adrenergic α1, dopamine D2, and dopamine D3 receptors. It is also reported to block adrenergic α2 receptors in guinea pig vas deferens. SB-269970 has been used to target the 5-HT7 receptor in the study of schizophrenia-like cognitive deficits.
CAS Number
261901-57-9 (HCl)
Chemical Formula
C18H29ClN2O3S
Exact Mass
352.1821
Molecular Weight
388.951
Elemental Analysis
C, 55.58; H, 7.52; Cl, 9.11; N, 7.20; O, 12.34; S, 8.24
Synonym
SB269970; SB 269970; SB-269970; GR125743; GR-125743; GR 125743; SB269970 HCl.
IUPAC/Chemical Name
3-[(2R)-2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidine-1-sulfonyl]phenol hydrochloride
InChi Key
XQCJOYZLWFNDIO-PKLMIRHRSA-N
InChi Code
InChI=1S/C18H28N2O3S.ClH/c1-15-7-11-19(12-8-15)13-9-16-4-3-10-20(16)24(22,23)18-6-2-5-17(21)14-18;/h2,5-6,14-16,21H,3-4,7-13H2,1H3;1H/t16-;/m1./s1
SMILES Code
OC1=CC=CC(S(=O)(N2[C@@H](CCN3CCC(C)CC3)CCC2)=O)=C1.[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4℃ for short term (days to weeks), or -20℃ for long term (months).
HS Tariff Code
2934.99.9001
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Enter Your Email to Subscribe

Enter your E-mail and receive the latest news from us

Copyright © Ace Therapeutics. All Rights Reserved.
Top